Meet the young women unlocking new ways to treat diseases and shaping the future of medicine

It's still relatively uncommon to see female leaders in the biotech and pharmaceutical industries.

In biotech, it's estimated that only about 7-9% of chief executive roles are filled by women. It's not an issue that's unique to drugmakers: Among the Fortune 500, 6.4% were led by female CEOs.

But among the generation of leaders under 40, there are a number of women who are building companies, unlocking new ways to treat cancer, and harnessing revolutionary gene-editing tools.

Business Insider intitially came up with a list of 30 leaders, through nominations and past coverage, who are shaping the future of medicine. Of that list, half were women. We asked them what the contribution the under-40 generation would have on medicine.

Here's who's doing groundbreaking work as young female leaders under 40 in biopharma, listed alphabetically.